ID | PEPTIDE SEQUENCE | PEPTIDE NAME | LENGTH | CHIRALITY | LINEAR/CYCLIC | SOURCE | CATEGORY | N TERMINAL MODIFICATION | C TERMINAL MODIFICATION | CHEMICAL MODIFICATION | CARGO | PUBMED ID |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2002 | RRRRRRRGGIYLATALAKWALKQGF | P7-4 | 25 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-27 | 23262194 |
2003 | IYLATALAKWALKQGFGGRRRRRRR | P7-5 | 25 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-27 | 23262194 |
2004 | RRRRRRRGGIYLATALAKWALKQ | P7-6 | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-26 | 23262194 |
2005 | IYLATALAKWALKQGGRRRRRRR | P7-7 | 23 | L | Linear | Synthetic | Cationic | Free | Free | NA | Fluorophore [DiSC3(5)] and peptide P7-26 | 23262194 |
2022 | NYRWRCKNQN | ECP(32-41) | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Fluorophore (FITC), Protein (eGFP) and Peptide (KLA) | 23469189 |
2034 | KLAKLAKKLAKLAKGRKKRRQRRRP | KLA-TAT(47-57) | 25 | L | Linear | Chimeric | Cationic | Free | Free | NA | Peptide (KLA) | 23469189 |
2035 | KLAKLAKKLAKLAKNYRWRCKNQN | KLA-ECP(32-41) | 24 | L | Linear | Chimeric | Cationic | Free | Free | NA | Peptide (KLA) | 23469189 |
2061 | GGRRARRRRRR | CTP | 11 | L | Linear | Protein derived | NA | Free | Free | NA | Peptide (HBcAg18 27-Tapasin) | 23299079 |
2089 | YGRKKRRQRRR | 6His-TAT-Ainp1 | 11 | L | Linear | Protein derived | Cationic | Free | Free | Histidine tagged | Peptide (Ainp1) | 23454269 |
2233 | CRQIKIWFQNRRMKWKK | Penetratin | 17 | L | Linear | Protein derived | Cationic and amphipathic | Acetylation | Amidation | NA | Peptide (KLA) and Nanoparticle (DSPC and DSPG liposomes) | 24796502 |
2234 | CRQIKIWFQNRRMKWKKKLAKLAKKLAKLAK | KLA-Pen | 31 | L | Linear | Chimeric | Amphipathic | Acetylation | Amidation | NA | Peptide (KLA) and Nanoparticle (DSPC and DSPG liposomes) | 24796502 |
2239 | RKKNPNCRRH | hBCPP | 10 | L | Linear | Protein derived | Cationic | Free | Free | NA | Peptide (Smurf1-binding peptide) | 24831974 |
2244 | Cyclo (FΦRRRRQ) | cFΦR4-R5 | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine | Peptide (RRRRR) | 24896852 |
2245 | Cyclo (FΦRRRRQ) | cFΦR4-A5 | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine | Peptide (AAAAA) | 24896852 |
2246 | Cyclo (FΦRRRRQ) | cFΦR4-F4 | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine | Peptide (FFFF) | 24896852 |
2247 | Cyclo (FΦRRRRQ) | cFΦR4-PCP | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine,miniPEG, 8-amino-3,6-dioxaoctanoic acid | Peptide [PCP, miniPEG-DE(pCAP)LI-NH2] | 24896852 |
2248 | RRRRRRRRR | R9-PCP | 9 | L | Linear | Synthetic | Cationic | Acetylation | Amidation | Φ, L-2-naphthylalanine,miniPEG, 8-amino-3,6-dioxaoctanoic acid | Peptide [PCP, miniPEG-DE(pCAP)LI-NH2] | 24896852 |
2249 | RKKRRQRRR | Tat-PCP | 9 | L | Linear | Protein derived | Cationic | Acetylation | Amidation | Φ, L-2-naphthylalanine,miniPEG, 8-amino-3,6-dioxaoctanoic acid | Peptide [PCP, miniPEG-DE(pCAP)LI-NH2] | 24896852 |
2250 | RQIKIWFQNRRMKWKK | Antp-PCP | 16 | L | Linear | Protein derived | Cationic and amphipathic | Acetylation | Amidation | Φ, L-2-naphthylalanine,miniPEG, 8-amino-3,6-dioxaoctanoic acid | Peptide [PCP, miniPEG-DE(pCAP)LI-NH2] | 24896852 |
2251 | Cyclo (FΦRRRRQ) | bicyclo(FΦR4-A5)Rho | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine, J, l-2,3-diaminopropionic acid, Tm, trimesoyl | Cyclic peptide (Tm(AAAAA)) | 24896852 |
2252 | Cyclo (FΦRRRRQ) | bicyclo(FΦR4-A7)Rho | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine, J, l-2,3-diaminopropionic acid, Tm, trimesoyl | Cyclic peptide Tm(AAAAAAA)K | 24896852 |
2253 | Cyclo (FΦRRRRQ) | bicyclo(FΦR4-RARAR)Rho | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine, J, l-2,3-diaminopropionic acid, Tm, trimesoyl | Cyclic peptide Tm(RARAR)K | 24896852 |
2254 | Cyclo (FΦRRRRQ) | bicyclo(FΦR4-DADAD)Rho | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine, J, l-2,3-diaminopropionic acid, Tm, trimesoyl | Cyclic peptide Tm(DADAD)K | 24896852 |
2255 | Cyclo (FΦRRRRQ) | monocyclo(FΦR4-A5)Rho | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine | Peptide AAAAA | 24896852 |
2256 | Cyclo (FΦRRRRQ) | monocyclo(FΦR4-A7)Rho | 8 | Modified | Cyclic | Synthetic | Amphipathic | Free | Amidation | Φ, L-2-naphthylalanine | Peptide AAAAAAA | 24896852 |
2257 | RRIRPRPPRLPRPRPRPLPFPRPG | Bac-ELP43 | 24 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [ELP (Elastin like peptide sequence), Fluorophore (Alexa-Fluor)] | 24866938 |
2258 | RRIRPRPPRLPRPRPRPLPFPRPG | Bac-ELP63 | 24 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [ELP (Elastin like peptide sequence), Fluorophore (Alexa-Fluor)] | 24866938 |
2259 | RRIRPRPPRLPRPRPRPLPFPRPG | Bac-ELP122 | 24 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [ELP (Elastin like peptide sequence), Fluorophore (Alexa-Fluor)] | 24866938 |
2311 | YGRKKRRQRRR | TAT(47-57) | 11 | L | Linear | Protein derived | Cationic | Free | Free | NA | Peptide (Mitochondrial Target Domain of NOXA) | 24416126 |
2312 | RQIKIWFQNRRMKWKK | Penetratin | 16 | L | Linear | Protein derived | Cationic and amphipathic | Free | Free | NA | Peptide (Mitochondrial Target Domain of NOXA) | 24416126 |
2313 | KETWWETWWTEWSQPKKKRKV | PEP-1 | 21 | L | Linear | Synthetic | NA | Free | Free | NA | Peptide (Mitochondrial Target Domain of NOXA) | 24416126 |
2314 | RIMRILRILKLAR | DS4.3 | 13 | L | Linear | Protein derived | NA | Free | Free | NA | Peptide (Mitochondrial Target Domain of NOXA) | 24416126 |
2345 | RRRRR | Arg5-ELPBC | 5 | L | Linear | Synthetic | Cationic | Conjugation with ELPBC | Free | NA | Peptide (BH3 peptide drug and ELPBC) | 24611762 |
2346 | RRRRRRRR | Arg8-ELPBC | 8 | L | Linear | Synthetic | Cationic | Conjugation with ELPBC | Free | NA | Peptide (BH3 peptide drug and ELPBC) | 24611762 |
2347 | YGRKKRRQRRR | TAT-ELPBC | 11 | L | Linear | Protein derived | Cationic | Conjugation with ELPBC | Free | NA | Peptide (BH3 peptide drug and ELPBC) | 24611762 |
2348 | YGRGGRRGRRR | RTAT-ELPBC | 11 | L | Linear | Synthetic | Cationic | Conjugation with ELPBC | Free | NA | Peptide (BH3 peptide drug and ELPBC) | 24611762 |
2393 | WELVVLGKL-YGRKKRRQRRR | pep5-cpp | 20 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 derivative (WELVVLGKL)] | 24764300 |
2394 | ELVVLGKL-YGRKKRRQRRR | N-pep5-cpp | 19 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (ELVVLGKL)] | 24764300 |
2395 | LVVLGKL-YGRKKRRQRRR | N2-pep5-cpp | 18 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (LVVLGKL)] | 24764300 |
2396 | VVLGKL-YGRKKRRQRRR | N3-pep5-cpp | 17 | L | Linear | Synthetic | Cationic | Free | Free | NA | peptide [Pep-5 (VVLGKL)] | 24764300 |
2397 | WELVVLGK-YGRKKRRQRRR | C1-pep5-cpp | 19 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WELVVLGK)] | 24764300 |
2398 | WELVVLG-YGRKKRRQRRR | C2-pep5-cpp | 18 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WELVVLG)] | 24764300 |
2399 | WELVVL-YGRKKRRQRRR | C3-pep5-cpp* | 17 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WELVVL)] | 24764300 |
2400 | WELVV-YGRKKRRQRRR | C4-pep5-cpp | 16 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WELVV)] | 24764300 |
2401 | WELV-YGRKKRRQRRR | C5-pep5-cpp | 15 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WELV)] | 24764300 |
2402 | WEL-YGRKKRRQRRR | C6-pep5-cpp | 14 | L | Linear | Synthetic | Cationic | Free | Free | NA | peptide [Pep-5 (WEL)] | 24764300 |
2403 | WE-YGRKKRRQRRR | C7-pep5-cpp | 13 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WE)] | 24764300 |
2404 | WELVVA-YGRKKRRQRRR | A | 17 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WELVVA)] | 24764300 |
2405 | WEAVVL-YGRKKRRQRRR | B | 17 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WEAVVL)] | 24764300 |
2406 | WEAVVA-YGRKKRRQRRR | C | 17 | L | Linear | Synthetic | Cationic | Free | Free | NA | Peptide [Pep-5 (WEAVVA)] | 24764300 |